Shares of UnitedHealth Group (NYSE: UNH) were rallying on Tuesday, up 10.5% as of 1:41 p.m. EDT. UnitedHealth is the largest health insurer in America, and received a boost today after the government's Centers for Medicare & Medicaid Services announced a higher 2027 reimbursement rate for Medicare Advantage plans than previously indicated. In a statement from CMS Administrator Mehmet Oz (or "Dr. O...
Shares of UnitedHealth Group (NYSE: UNH) were rallying on Tuesday, up 10.5% as of 1:41 p.m. EDT. UnitedHealth is the largest health insurer in America, and received a boost today after the government's Centers for Medicare & Medicaid Services announced a higher 2027 reimbursement rate for Medicare Advantage plans than previously indicated. In a statement from CMS Administrator Mehmet Oz (or "Dr. Oz" as he's known to many), the government agency announced it had approved a 2.48% increase to Medicare Advantage reimbursements for calendar 2027. Continue reading
Parents face child endangerment charge after their kid suffered a minor injury at ZooAmerica in Hersheypark The parents of a toddler who suffered a minor injury at a Pennsylvania theme park zoo after squeezing through a fence near a wolf enclosure and making contact with one of the animals have been charged with endangering the welfare of children, with police accusing them of paying attention to ...
Parents face child endangerment charge after their kid suffered a minor injury at ZooAmerica in Hersheypark The parents of a toddler who suffered a minor injury at a Pennsylvania theme park zoo after squeezing through a fence near a wolf enclosure and making contact with one of the animals have been charged with endangering the welfare of children, with police accusing them of paying attention to their cellphones at the time. In a news release, police said that the parents both walked about 25ft to 30ft (7.5 meters to 9 meters) away from the child to a seating area with benches and appeared to be paying attention to their cellphones when they noticed what was happening Saturday at ZooAmerica in Hersheypark. Continue reading...
Carolina Wealth Advisors, LLC fully exited its RPC (NYSE:RES) stake in the first quarter, selling 1,252,201 shares for an estimated $7.80 million based on average pricing, according to an April 7, 2026, SEC filing. According to a filing with the Securities and Exchange Commission dated April 7, 2026, Carolina Wealth Advisors, LLC sold all 1,252,201 shares of RPC during the first quarter. The estim...
Carolina Wealth Advisors, LLC fully exited its RPC (NYSE:RES) stake in the first quarter, selling 1,252,201 shares for an estimated $7.80 million based on average pricing, according to an April 7, 2026, SEC filing. According to a filing with the Securities and Exchange Commission dated April 7, 2026, Carolina Wealth Advisors, LLC sold all 1,252,201 shares of RPC during the first quarter. The estimated value of the trade was approximately $7.80 million, calculated using the average quarterly closing price. The fund’s position in RPC decreased by $6.81 million in value from the previous quarter-end, reflecting both the sale and share price moves. The fund fully exited its RPC stake; it now represents 0% of 13F reportable assets under management. Continue reading
Shoppers might want to consider a used electric vehicle at least to lessen the pain at the pump. On Tuesday, Cox Automotive released the latest Manheim Used Vehicle Value Index, a common measure of used car pricing. “All major vehicle segments are above year-earlier levels; however, the luxury segment continues to outperform the overall market,” said Jeremy Robb, Cox Automotive’s chief economist, ...
Shoppers might want to consider a used electric vehicle at least to lessen the pain at the pump. On Tuesday, Cox Automotive released the latest Manheim Used Vehicle Value Index, a common measure of used car pricing. “All major vehicle segments are above year-earlier levels; however, the luxury segment continues to outperform the overall market,” said Jeremy Robb, Cox Automotive’s chief economist, in a news release.
Apple (NASDAQ: AAPL) stock is moving lower in Tuesday's trading amid two main bearish catalysts. The company's share price was down 2.9% as of 2:35 p.m. ET. At the same point in the daily session, the S&P 500 was down 0.5%, and the Nasdaq Composite was down 0.7%. The stock had been down as much as 5.1% but has narrowed its losses. The broader market is seeing bearish momentum today as investors re...
Apple (NASDAQ: AAPL) stock is moving lower in Tuesday's trading amid two main bearish catalysts. The company's share price was down 2.9% as of 2:35 p.m. ET. At the same point in the daily session, the S&P 500 was down 0.5%, and the Nasdaq Composite was down 0.7%. The stock had been down as much as 5.1% but has narrowed its losses. The broader market is seeing bearish momentum today as investors react to war-related risks. Apple stock is also under pressure in response to a new analyst note. Image source: Getty Images. Continue reading
Andreas Rentz/Getty Images News The head of U.S. operations at Bayer ( BAYZF ) told Reuters on Tuesday that the German drugmaker doesn’t see a requirement to revise its 2026 estimates to account for the Trump administration’s recently imposed tariffs on pharmaceutical imports. Last week, President Donald Trump signed an executive order introducing new tariffs on pharma and biotech firms that have ...
Andreas Rentz/Getty Images News The head of U.S. operations at Bayer ( BAYZF ) told Reuters on Tuesday that the German drugmaker doesn’t see a requirement to revise its 2026 estimates to account for the Trump administration’s recently imposed tariffs on pharmaceutical imports. Last week, President Donald Trump signed an executive order introducing new tariffs on pharma and biotech firms that have not reached "most favored nation" drug pricing deals with the White House. The levies expected to take effect for most companies in September could impact Bayer ( BAYRY ), as the German drugmaker is not among the 16 pharma companies that have already entered into such agreements with the U.S. "We feel that we've appropriately anticipated tariffs as we think about our 2026 guidance," said Sebastian Guth, who serves as head of Bayer's ( BAYRY ) U.S. business and the chief operating officer of its pharma division In March, Bayer ( BAYZF ) estimated €9.1B - €9.6B ($10.6B - $11.2B) of adjusted EBITDA for 2026, falling short of the €9.67B projected by analysts. He added that the company is particularly at ease with its outlook because the U.S. is committed to its 2025 trade deal with the EU that sets a 15% baseline tariff on nearly all imports from the bloc. Guth also referred to a recently finalized U.S.- UK pharmaceutical trade deal under which Britain agreed to boost its drug spending to 0.6% from 0.3% of GDP over the years in exchange for tariff-free access to the U.S. He identified the deal as a basis on which rich countries can make decisions about changing their pricing structures. "There's an acknowledgment that it isn't going to happen overnight but will happen over time," Guth said. More on Bayer Bayer: Turnaround Is Underway - Don't Miss It Bayer Aktiengesellschaft 2025 Q4 - Results - Earnings Call Presentation Bayer Aktiengesellschaft (BAYRY) Q4 2025 Earnings Call Transcript Bayer pushes for higher drug prices in talks with wealthier nations Ubben’s Inclusive Capita...
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Wall Street pulled back Tuesday as President Donald Trump's deadline for Iran to reopen the Strait of Hormuz — or face potential strikes on key infrastructure — draws closer. By midday, the S & P 500's decline largely unwound Mo...
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Wall Street pulled back Tuesday as President Donald Trump's deadline for Iran to reopen the Strait of Hormuz — or face potential strikes on key infrastructure — draws closer. By midday, the S & P 500's decline largely unwound Monday's gains, a reasonable move given how difficult it is to game out the Trump administration's next steps. Oil remained higher in the session, with U.S. oil benchmark West Texas Intermediate crude up about $3 to $115 per barrel. Bonds yields moved up, with the 10-Year yield up roughly 2 basis points. Our strategy to navigate this uncertain moment: We're sitting on our hands Tuesday, reluctant to deploy new money on concerns that an escalation in the war would lead to an immediate pullback in whatever we buy. And if cooler heads prevail, we should capture that upside across the 31 stocks in the portfolio. Apple shares dropped as much as 5% in Tuesday's session on a report that its upcoming foldable iPhone may be facing delays, but new information suggests that story was wrong. Accordingly, the stock is well off its lows of the day in afternoon trading. Earlier Tuesday, Nikkei Asia reported that the iPhone maker experienced a setback in the engineering test phase, which could push back its production and shipment timeline by several months. The Nikkei story was later refuted by Bloomberg, which reported the foldable iPhone model is still on track for a September launch, citing people with knowledge of the matter. The market is very excited that Apple is coming out with a foldable smartphone, explaining the initial emotional reaction in the stock. We're also quite bullish about the new device. People don't get too excited by camera upgrades anymore. To unlock a major upgrade cycle, Apple needs to deliver on new AI powered features or develop a new form factor. A larger, fold...
Lean hog futures are 7 to 60 cents lower in the front months at Tuesday’s midday. USDA’s national base hog price was reported at $90.83 on Tuesday morning. The CME Lean Hog Index was down another 8 cents on April 3 at $89.93. USDA’s pork carcass cutout value from the...
Lean hog futures are 7 to 60 cents lower in the front months at Tuesday’s midday. USDA’s national base hog price was reported at $90.83 on Tuesday morning. The CME Lean Hog Index was down another 8 cents on April 3 at $89.93. USDA’s pork carcass cutout value from the...
Corn prices are down 3 to 5 cents so far on Tuesday’s midday. The CmdtyView national average Cash Corn price is down 5 cents at $4.09 1/4. Crude oil is up $2.48 at midday ahead of President Trump’s Tuesday night deadline for Iran. Corn longs may be taking some risk...
Corn prices are down 3 to 5 cents so far on Tuesday’s midday. The CmdtyView national average Cash Corn price is down 5 cents at $4.09 1/4. Crude oil is up $2.48 at midday ahead of President Trump’s Tuesday night deadline for Iran. Corn longs may be taking some risk...
Soybeans are showing 9 to 11 cent losses in the front months on Tuesday. The cmdtyView national average Cash Bean price is down 10 1/2 cents at $10.87 1/2. Soymeal futures are down $$3.70 to $5 in the front months, with Soy Oil futures down 15 to 25 points at...
Soybeans are showing 9 to 11 cent losses in the front months on Tuesday. The cmdtyView national average Cash Bean price is down 10 1/2 cents at $10.87 1/2. Soymeal futures are down $$3.70 to $5 in the front months, with Soy Oil futures down 15 to 25 points at...
The wheat complex is mixed at midday, with the soft red contracts higher. Chicago SRW futures are fractionally to a penny in the front months so far on the day. KC HRW futures are trading with 2 to 3 cent losses on Tuesday. MPLS spring wheat is down 2 cents...
The wheat complex is mixed at midday, with the soft red contracts higher. Chicago SRW futures are fractionally to a penny in the front months so far on the day. KC HRW futures are trading with 2 to 3 cent losses on Tuesday. MPLS spring wheat is down 2 cents...